U.S. and European stocks futures moved higher on Monday as Asian markets lagged, while bonds surrendered some of their recent gains and oil rallied as Saudi Arabia lifted its crude prices.
Toyota Motor Corp (7203.T) will launch an all-electric small sedan in China late next year, having turned to local partner BYD (002594.SZ) for key technology to finally make an affordable yet roomy runaround, four sources told Reuters.
Dating app Tinder is exploring how to blur the boundaries between offline and online worlds, CEO Renate Nyborg said in an interview at the Reuters Next conference.
Alphabet Inc’s (GOOGL.O) Google said on Thursday it is indefinitely pushing back its January return-to-office plan globally amid growing concerns over the Omicron variant of the coronavirus and some resistance to company-mandated vaccinations.
Singapore’s digital banks will find it hard to carve out space in the city-state’s saturated market, said Piyush Gupta, the CEO of DBS Group (DBSM.SI), Southeast Asia’s biggest lender.
Ride-hailing giant Didi Global (DIDI.N) said it will delist from the New York stock exchange just five months after its debut and pursue a listing in Hong Kong – having raised the ire of Chinese regulators for ignoring a request to put its U.S. IPO on hold.
Chinese property developer Kaisa Group Holdings Ltd (1638.HK) said on Friday it failed to secure the minimum 95% approval it needed from offshore bondholders to extend the maturity of a $400 million note due next week, raising the risk of a default.
Shares in Japanese conglomerate SoftBank Group Corp (9984.T) dropped over 3% on Friday after the giant tech investor was hit with three disappointments within 24 hours, including a poor Nasdaq debut for ride-hailing firm Grab (GRAB.O).
Australia, despite restrictions on international visitors, became the latest country on Friday to report community transmission of Omicron, a day after the coronavirus variant was found locally in five U.S. states.
As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.
U.S. and European stocks futures moved higher on Monday as Asian markets lagged, while bonds surrendered some of their recent gains and oil rallied as Saudi Arabia lifted its crude prices.
Toyota Motor Corp (7203.T) will launch an all-electric small sedan in China late next year, having turned to local partner BYD (002594.SZ) for key technology to finally make an affordable yet roomy runaround, four sources told Reuters.
Dating app Tinder is exploring how to blur the boundaries between offline and online worlds, CEO Renate Nyborg said in an interview at the Reuters Next conference.
Alphabet Inc’s (GOOGL.O) Google said on Thursday it is indefinitely pushing back its January return-to-office plan globally amid growing concerns over the Omicron variant of the coronavirus and some resistance to company-mandated vaccinations.
Singapore’s digital banks will find it hard to carve out space in the city-state’s saturated market, said Piyush Gupta, the CEO of DBS Group (DBSM.SI), Southeast Asia’s biggest lender.
Ride-hailing giant Didi Global (DIDI.N) said it will delist from the New York stock exchange just five months after its debut and pursue a listing in Hong Kong – having raised the ire of Chinese regulators for ignoring a request to put its U.S. IPO on hold.
Chinese property developer Kaisa Group Holdings Ltd (1638.HK) said on Friday it failed to secure the minimum 95% approval it needed from offshore bondholders to extend the maturity of a $400 million note due next week, raising the risk of a default.
Shares in Japanese conglomerate SoftBank Group Corp (9984.T) dropped over 3% on Friday after the giant tech investor was hit with three disappointments within 24 hours, including a poor Nasdaq debut for ride-hailing firm Grab (GRAB.O).
Australia, despite restrictions on international visitors, became the latest country on Friday to report community transmission of Omicron, a day after the coronavirus variant was found locally in five U.S. states.
As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.
© | All rights reserved.
